Download PDF
CC BY-NC-ND 4.0 · Indian J Radiol Imaging 2024; 34(03): 539-544
DOI: 10.1055/s-0044-1779689
Case Series

Image-Guided Percutaneous Sclerotherapy for Orbital Low-Flow Malformation: Our Experience

Gautam Lokdarshi 
1   Oculoplastic and Ocular Oncology Services, IRIS Superspeciality Eye Hospital, Orchid Medical Centre, Ranchi, Jharkhand, India
,
Shwetam Kumar
2   Radiology Services, Orchid Medical Centre, Ranchi, Jharkhand, India
,
Subhash Kumar
3   Department of Radiology, All India Institute of Medical Sciences, Patna, Bihar, India
,
Nitu Nitu
2   Radiology Services, Orchid Medical Centre, Ranchi, Jharkhand, India
,
Nripen Gaur
4   Department of Ophthalmology, All India Institute of Medical Sciences, Bilaspur, Himachal Pradesh, India
› Author Affiliations Funding None.
› Further Information
Also available at
   Permissions and Reprints

Abstract

For a safe sclerotherapy session to be completed in the orbital low-flow malformation (namely lymphovenous malformation or venolymphatic malformation), accurate identification of the target lesion for the drug injection is crucial. Regarding the dependability and viability of the injection approach, the authors have discussed their experiences with image-guided percutaneous sclerotherapy on a few patients.

Keywords

sclerotherapy - orbital - low-flow malformation - image-guided - LVM - fluoroscopy

Patient Consent

An informed consent was taken from the parents of the patient for publishing their data.


Ethical Approval

This study complies with the Declaration of Helsinki and CARE guidelines.


Authors' Contributions

G.L., Sh.K., Su.K., N.N., and N.G. prepared and edited and reviewed the manuscript. G.L. helped in data collection and literature search. G.L., Sh.K., Su.K., N.N., and N.G. helped in approval of the manuscript .




Publication History

Article published online:
28 February 2024

© 2024. Indian Radiological Association. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

Letter to this article:

Never Regret Trying Image-Guided Sclerotherapy in Orbital Low-Flow MalformationIndian J Radiol Imaging eFirst
DOI: 10.1055/s-0044-1788552

 

  • References

  • 1 Rootman J. Diseases of the Orbit: A Multidisciplinary Approach. 2nd ed.. Philadelphia, USA: Lippincott Williams and Wilkins; 2003: 522-528
    Google Scholar
  • 2 Putthirangsiwong B, Selva D, Chokthaweesak W, Chanthanaphak E, Singhara Na Ayudhaya S. Orbital lymphatic-venous malformation with concomitant spontaneous orbital arteriovenous fistula: case report. J Neurosurg Pediatr 2018; 21 (02) 141-144
    CrossrefPubMedGoogle Scholar
  • 3 Chen Y, Choi CJ, Lee BW. Bleomycin sclerotherapy of a distensible orbital venous malformation without image guidance. Can J Ophthalmol 2019; 54 (03) e120-e123
    CrossrefPubMedGoogle Scholar
  • 4 De Maria L, De Sanctis P, Tollefson M. et al. Sclerotherapy for low-flow vascular malformations of the orbital and periocular regions: systematic review and meta-analysis. Surv Ophthalmol 2020; 65 (01) 41-47
    CrossrefPubMedGoogle Scholar
  • 5 Lam SC, Yuen HKL. Medical and sclerosing agents in the treatment of orbital lymphatic malformations: what's new?. Curr Opin Ophthalmol 2019; 30 (05) 380-385
    CrossrefPubMedGoogle Scholar
  • 6 Abdelaziz O, Hassan F, Elessawy K, Emad-Eldin S, Essawy RE. Image-guided percutaneous bleomycin and bevacizumab sclerotherapy of orbital lymphatic malformations in children. Cardiovasc Intervent Radiol 2019; 42 (03) 433-440
    CrossrefPubMedGoogle Scholar
  • 7 Rootman DB, Diniz SB, Cohen LM. Clinical assessment and lesion-specific management of orbital vascular malformations. J Neurol Surg B Skull Base 2021; 82 (01) 116-128
    Article in Thieme ConnectPubMedGoogle Scholar